Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report

Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report

Abstract Recurrent herpes simplex virus or varicella zoster virus infection should be considered as one of the rare complications after AstraZeneca vaccination for COVID‐19.

Guardado en:
Detalles Bibliográficos
Autores principales: Mohammadreza Ardalan, Hamidreza Moslemi, Shervin Shafiei, Reza Tabrizi, Mohammadreza Moselmi
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Chadox1 ncov‐19 vaccine
COVID‐19
COVID‐19 vaccines
herpes simplex
varicella zoster
Medicine
R
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/71f293ba571f4ef4a637a7fbbbc2cb15
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:71f293ba571f4ef4a637a7fbbbc2cb15
record_format dspace
spelling oai:doaj.org-article:71f293ba571f4ef4a637a7fbbbc2cb152021-12-02T07:55:56ZHerpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report2050-090410.1002/ccr3.4883https://doaj.org/article/71f293ba571f4ef4a637a7fbbbc2cb152021-10-01T00:00:00Zhttps://doi.org/10.1002/ccr3.4883https://doaj.org/toc/2050-0904Abstract Recurrent herpes simplex virus or varicella zoster virus infection should be considered as one of the rare complications after AstraZeneca vaccination for COVID‐19.Mohammadreza ArdalanHamidreza MoslemiShervin ShafieiReza TabriziMohammadreza MoselmiWileyarticleChadox1 ncov‐19 vaccineCOVID‐19COVID‐19 vaccinesherpes simplexvaricella zosterMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic Chadox1 ncov‐19 vaccine
COVID‐19
COVID‐19 vaccines
herpes simplex
varicella zoster
Medicine
R
Medicine (General)
R5-920
spellingShingle Chadox1 ncov‐19 vaccine
COVID‐19
COVID‐19 vaccines
herpes simplex
varicella zoster
Medicine
R
Medicine (General)
R5-920
Mohammadreza Ardalan
Hamidreza Moslemi
Shervin Shafiei
Reza Tabrizi
Mohammadreza Moselmi
Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report
description Abstract Recurrent herpes simplex virus or varicella zoster virus infection should be considered as one of the rare complications after AstraZeneca vaccination for COVID‐19.
format article
author Mohammadreza Ardalan
Hamidreza Moslemi
Shervin Shafiei
Reza Tabrizi
Mohammadreza Moselmi
author_facet Mohammadreza Ardalan
Hamidreza Moslemi
Shervin Shafiei
Reza Tabrizi
Mohammadreza Moselmi
author_sort Mohammadreza Ardalan
title Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report
title_short Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report
title_full Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report
title_fullStr Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report
title_full_unstemmed Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report
title_sort herpes‐like skin lesion after astrazeneca vaccination for covid‐19: a case report
publisher Wiley
publishDate 2021
url https://doaj.org/article/71f293ba571f4ef4a637a7fbbbc2cb15
work_keys_str_mv AT mohammadrezaardalan herpeslikeskinlesionafterastrazenecavaccinationforcovid19acasereport
AT hamidrezamoslemi herpeslikeskinlesionafterastrazenecavaccinationforcovid19acasereport
AT shervinshafiei herpeslikeskinlesionafterastrazenecavaccinationforcovid19acasereport
AT rezatabrizi herpeslikeskinlesionafterastrazenecavaccinationforcovid19acasereport
AT mohammadrezamoselmi herpeslikeskinlesionafterastrazenecavaccinationforcovid19acasereport
_version_ 1718399107984261120

Ejemplares similares